33
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Differential Effects of the MDR1 (Multidrug Resistance) Gene-Activating Agents on Protein Kinase C: Evidence for Redundancy of Mechanisms of Acquired MDR in Leukemia Cells

, , &
Pages 191-195 | Received 28 Mar 2000, Published online: 01 Jul 2009

References

  • Friedenberg W. R., Spencer S. K., Musser C., Hogan T. F., Rodvold K. A., Rushing D. A., Mazza J J., Tewksbury D. A., Marx J. J. Multidrug resistance in chronic lymphocytic leukemia. Leuk. Lymphoma 1999; 34: 171–178
  • Chaudhary P., Roninson I. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncology Res. 1992; 4: 281–290
  • Chaudhary P., Roninson I. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst. 1993; 85: 632–639
  • Hu X. F., Slater A., Kantharidis P., Rischin D., Juneja S., Rossi R., Lee G., Parkin J. D., Zalcberg J. R. Altered multidrug resistance phenotype caused by anthracy-cline analogues and cytosine arabinoside in myeloid leukemia. Blood 1999; 93: 4086–4095
  • Walter R. J., Shtil A. A., Roninson I. B., Holian O. 60-Hz electric fields inhibit protein kinase C activity and multidrug resistance gene (MDR1) up-regulation. Radiation Res. 1997; 147: 369–375
  • Bose R., Verheij M., Haimovitz-Friedman A., Scotto K., Fuks Z., Kolesnick R. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 1995; 82: 405–414
  • Garzotto M., White-Jones M., Jiang Y., Ehleiter D., Liao W. C., Haimovitz-Friedman A., Fuks Z., Kolesnick R. 12-O-tetradecanoylphorbol 13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. Cancer Res. 1998; 58: 2260–2264
  • Komarov P. G., Shtil A. A., Holian O., Tee L., Mechetner E. B., Roninson I., Coon J. Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine. Oncology Res. 1998; 10: 185–192
  • Hannun Y. Q., Bell R. M. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 1989; 243: 500–507
  • Tanabe F., Cui S. H., Ito M. Ceramide promotes calpain-mediated proteolysis of protein kinase C beta in murine polymorphonuclear leukocytes. Biochem. Biophys. Res. Commun. 1998; 242: 129–133
  • Jaffrezou J. P., Levade T., Bettalieb A., Andrieu N., Bez-Ombes C., Maestre N., Vermeersch S., Rousse A., Laurent G. Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBOJ. 1996; 15: 2417–2424
  • Sato T., Kageura T., Hashizume T., Hayama M., Kitatani K., Akiba S. Stimulation by ceramide of phospholipase A2 activation through a mechanism related to phospholipase C-initiated signaling pathways in rabbit platelets. J. Biochem. 1999; 125: 96–102
  • Abolhoda A., Wilson A. E., Ross H., Danenberg P. V., Burt M., Scotto K. W. Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin. Clin. Cancer Res. 1999; 5: 3352–3356
  • Scotto K. W., Egan D. A. Transcriptional regulation of MDR genes. Cytotechnology 1998; 27: 257–269
  • McCoy C., Smith D. E., Cornwell M. M. 12-O-tetradecanoylphorbol 13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol. Cell. Biol. 1995; 15: 6100–6108
  • Jin S., Scotto K. W. Transcriptional regulation of the MDR1 gene by histone acetytransferase and deacetylase is mediated by NF-Y. Mol. Cell. Biol. 1998; 18: 4377–4384
  • Hu Z., Jin S., Scotto K. W. Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Spl. J. Biol. Chem. 1999; 275: 2979–2985
  • Friedman D., Thayer S., Scotto K. W. Activation of MDRl transcription by ATRA in neuroblastoma cells is initiated by a complex interplay of multiple Sp1 family members. Proc. 90th Annual Meet. Amer. Assoc. Cancer Res. 1999; 666
  • Jin S., Lin Y., Magro P. G., Scotto K. W. Repression of MDR1 gene transcription by ecteinascidin 743. Proc. 90th Annual Meet. Amer. Assoc. Cancer Res. 1999; 314

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.